For corporate or product information, contact Cynosure at 800-886-2966, or visit http://www.cynosure.com.
Any statements in this press release about future expectations, plans
and prospects for Cynosure, Inc., including statements about the company's
expectations regarding the performance and market acceptance of the Affirm
CO2 and future financial performance, as well as other statements
containing the words "believes," "anticipates," "plans," "expects," "will"
and similar expressions, constitute forward-looking statements within the
meaning of The Private Securities Litigation Reform Act of 1995. Actual
results may differ materially from those indicated by such forward-looking
statements as a result of various important factors, including market
acceptance of the Affirm CO2, Cynosure's reliance on sole source suppliers,
the inability to accurately predict the timing or outcome of regulatory
decisions, changes in consumer preferences, competition in the aesthetic
laser industry, economic, market, technological and other factors discussed
in Cynosure's most recent Annual Report on Form 10-K and Form 10-Q each of
which is filed with the Securities and Exchange Commission. In addition,
the forward-looking statements included in this press release represent
Cynosure's views as of the date of this press release. Cynosure anticipates
that subsequent events and developments will cause its views to change.
However, while Cynosure may elect to update these forward-looking
statements at some point in the future, it specifically disclaims any
obligation to do so. These forward-looking statements should not be relied
upon as representing Cynosure's views as of any date subsequent to the date
of this press release.
|SOURCE Cynosure, Inc.|
Copyright©2008 PR Newswire.
All rights reserved